Caroline Solas

InstitutionAix-Marseille University
AddressFrance
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 13 Covid-19 publications, with a maximum of 3 publications in July 2020 and March 2021
    All Publications
    Bar chart showing 63 publications over 18 distinct years, with a maximum of 9 publications in 2011
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Doudka N, Giocanti M, Basso M, Ugdonne R, Barthelemy K, Lacarelle B, Blin O, Solas C, Guilhaumou R. Development and Validation of a Simple and Rapid Ultrahigh-Performance Liquid Chromatography Tandem Spectrometry Method for the Quantification of Hydroxychloroquine in Plasma and Blood Samples in the Emergency Context of SARS-CoV-2 Pandemic. Ther Drug Monit. 2021 08 01; 43(4):570-576. PMID: 33165216.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    2. Touret F, Driouich JS, Cochin M, Petit PR, Gilles M, Barthélémy K, Moureau G, Mahon FX, Malvy D, Solas C, de Lamballerie X, Nougairède A. Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Antiviral Res. 2021 09; 193:105137. PMID: 34265358.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    3. Driouich JS, Cochin M, Lingas G, Moureau G, Touret F, Petit PR, Piorkowski G, Barthélémy K, Laprie C, Coutard B, Guedj J, de Lamballerie X, Solas C, Nougairède A. Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun. 2021 03 19; 12(1):1735. PMID: 33741945.
      Citations: 22     Fields:    Translation:AnimalsCells
    4. Citations: 6     Fields:    Translation:Animals
    5. Stanke-Labesque F, Concordet D, Djerada Z, Bouchet S, Solas C, Mériglier E, Bonnet F, Mourvillier B, Ruiz S, Martin-Blondel G, Epaulard O, Schwebel C, Gautier-Veyret E, Gandia P. Neglecting Plasma Protein Binding in COVID-19 Patients Leads to a Wrong Interpretation of Lopinavir Overexposure. Clin Pharmacol Ther. 2021 04; 109(4):1030-1033. PMID: 33547636.
      Citations: 3     Fields:    Translation:HumansCells
    6. Kaptein SJF, Jacobs S, Langendries L, Seldeslachts L, Ter Horst S, Liesenborghs L, Hens B, Vergote V, Heylen E, Barthelemy K, Maas E, De Keyzer C, Bervoets L, Rymenants J, Van Buyten T, Zhang X, Abdelnabi R, Pang J, Williams R, Thibaut HJ, Dallmeier K, Boudewijns R, Wouters J, Augustijns P, Verougstraete N, Cawthorne C, Breuer J, Solas C, Weynand B, Annaert P, Spriet I, Vande Velde G, Neyts J, Rocha-Pereira J, Delang L. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Proc Natl Acad Sci U S A. 2020 10 27; 117(43):26955-26965. PMID: 33037151.
      Citations: 57     Fields:    Translation:AnimalsCells
    7. Lopez A, Duclos G, Pastene B, Bezulier K, Guilhaumou R, Solas C, Zieleskiewicz L, Leone M. Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results. Int J Antimicrob Agents. 2020 Nov; 56(5):106136. PMID: 32777263.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    8. Giaime P, Guenoun M, Pedinielli N, Narbonne H, Bergounioux JP, Solas C, Guilhaumou R, Sampol J, Ollier J, Sichez H, Serveaux M, Brunner F, Bataille S. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection. Nephrol Dial Transplant. 2020 08 01; 35(8):1346-1353. PMID: 32844224.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    9. Lemaitre F, Solas C, Grégoire M, Lagarce L, Elens L, Polard E, Saint-Salvi B, Sommet A, Tod M, Barin-Le Guellec C. Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments. Fundam Clin Pharmacol. 2020 Oct; 34(5):530-547. PMID: 32603486.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    10. Maisonnasse P, Guedj J, Contreras V, Behillil S, Solas C, Marlin R, Naninck T, Pizzorno A, Lemaitre J, Gonçalves A, Kahlaoui N, Terrier O, Fang RHT, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Calatrava MR, van der Werf S, de Lamballerie X, Le Grand R. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020 09; 585(7826):584-587. PMID: 32698191.
      Citations: 123     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    11. Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C. Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection. Antiviral Res. 2020 09; 181:104866. PMID: 32659293.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    12. Gougis P, Fenioux C, Funck-Brentano C, Veyri M, Gligorov J, Solas C, Spano JP. Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use? Eur J Cancer. 2020 09; 136:1-3. PMID: 32610172.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    13. Eloy P, Solas C, Touret F, Mentré F, Malvy D, de Lamballerie X, Guedj J. Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2. Clin Pharmacol Ther. 2020 08; 108(2):188. PMID: 32350860.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    Solas's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (166)
    Explore
    _
    Co-Authors (139)
    Explore
    _
    Similar People (60)
    Explore
    _